The interrelation between the deficiency of vitamin B12 and neurotoxicity of homocysteine with nitrite in some of neurologic disorders

Biogenic Amines

Volumn 14, Issue 1, 1998, Pages 1-14

  Baig, Shahid M ^a   Qureshi, G Ali ^b   Minami, Masaru ^c  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Cerebrospinal fluid; Homocysteine; Neurological disorders; Nitrite; Vitamin B12

Indexed keywords

ALBUMIN; ARGININE; CYANOCOBALAMIN; HOMOCYSTEINE; IMMUNOGLOBULIN G; NITRIC OXIDE; NITRITE;

ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROTOXICITY; PARKINSON DISEASE; TUBERCULOUS MENINGITIS; VITAMIN DEFICIENCY;

EID: 0031964130     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Baig, S.M. and Qureshi, G.A. (1995) Homocysteine and Vitamin B12 in Multiple Sclerosis. Biogenic Amine 11(6), 479-485.
2. Bank, R.G.S., Henderson, J.R. and Pratt, J.M. (1968) Reactions of gases in solution. III Some reactions of Nitric oxide with transition metal complexes. J.Chem.Soc. (A) 3, 2886-90.
3. Beal, M.F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness ?. Ann. Neurol 31, 119-130.
4. Beal, M.F. (1995) Aging, Energy and oxidative stress in neurodegenerative disease. Ann. Neurol. 38, 357-366.
5. Bondy, S.C. and LeBele, C.P. (1993) The relationship between excitotoxicity and oxidative stress in the central nervous system. Free Rad. Biol.Med. 14, 633-642.
6. Chanarin I., Deacon R., Lumb M., Muir M. and Perry J. (1988). Cobalamin folate interrations: A Critical Review. Blood 66, 479-482.
7. Chandefaux, B., Cooper, B.A., Gilfix, B.M., Lue-Shing, H., Carson, W., Gavsie, A. and Rosenbladt, D.S. (1994) Homocysteine: relationship to serum cobalamin, serum folate, erythrocyte folate, and lobation of neutrophils. Clin.Invest.Med 17, 540-550.
8. Coyle, J.T. and Puttfarcken, P. (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262, 689-694.
9. Crellin R.F., Bottiglieri T. and Reynolds E.H. (1990). Multiple sclerosis and macrocytosis, Acta. Neurol. Scand . 81, 388-91.
10. Cross, C.E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B.N., Saul, R.L., McCord, J.M. and Harman, D. (1987) Oxygen Radicals and Human Disease, Annal Int.Med. 107, 526-545.
11. Dawson, T.M., Dawson, V.L. and Snyder, S.H. (1992) A novel neuronal messager molecule in brain: The free radical, nitric oxide. Ann.Neurol. 32, 297-311.
12. Dawson, V.L. and Dawson, T.M. (1996) Free radicals and neuronal cell death. Cell Death and Differentiation 3, 71-78.
13. Deacon, R., Lamb, M. and Perry, J. (1978) Selective inactivation of vitamin B 12 in rats by nitrous oxide. Lancet 2, 1023-24.
14. Dexter, D.T., Holley, A.E. and Flitter, W.D. (1994). increased levels of lipid hydroperoxides in Parkinsonian substantia nigra : An HPLC and ESR study. Mov.Disord. 9, 92-97.
15. Dodd, P.R., Williams, S.H., Gundlach, A.L., Harper, P.A.W., Healy, P.J., Dennis, J.A. and Johnston, G.A.R. (1992) Glutamate and GABA neurotransmitter systems in the acute phase of Maple Syrup urine disease and citrullinemia encephalopathies in new born calves. J.Neurochem. 59, 582-590.
16. Drummond, J.T. and Methews, R.G. (1994) Nitrious oxide degradation by cobalamin-dependent synthase : Characterization of reactants and products in the inactivation reaction. Biochemistry 33, 3732-41.
17. Dykens, J.A., Stern, A. and Trenkner, E. (1987) Mechanisms of kainate toxicity tocerebellar neurons in vitro is analogue to reperfusion tissue injury. J.Neurochem. 49, 1222-1228.
18. Floyd, R. A. (1990). Role of oxygen free radicals in brain ischemia. FASEB J. 4, 2587-2592.
19. Frei, B. (1991) Ascorbic acid protects lipid in human plasma and low density lipoproteins against oxidative damage. Am.J.Clin.Nutri. 54, 1135-1145.
20. Futrell, N., Schultz, L.R. and Malliken, C. (1992) Central nervous system disease in patients with systemic lupus erythematosus. Neurology 42, 1649-1657.
21. Garthwaite, J. (1991) Glutamate,Nitric oxide and cell-cell signalling in the nervous system.Trends Neurosci. 14, 60-67.
22. Halawa, A., Baig, S. and Qureshi, G.A. (1996) Amino acids and nitrite in ischemic brain stroke. Biogenic Amines 12 (1), 27-36.
23. Hall, C.A. (1990) Function of Vitamin B12 in the central nervous system as revealed by congenital defects. Amr.J.Hemalt. 34, 121-127.
24. Halliwell, B. and Gutteridge, J.M.C. (1985) The importance of free radicals and catalytic metal ions in human diseases. Molec.Aspects Med. 8, 189-193.
25. Halliwell, B. and Gutteridge, J.M.C. (1989) Free radicals in biology and medicine, Clarendon Press, Oxfod.
26. Halliwell, B. (1992) Reactive oxygen species and the central nervous system. J.Neurochem. 59, 1609-1614.
27. Henry, R.J. (1992) Assessing environmental health concerns associated with nitric oxide. J.Amr.Dent.Assoc. 123, 41-47.
28. Herkenham, M. (1987) Mismatches between neurotransmitter and receptor localizations in brain: observations and implications.Neuroscience, 23, 1-38.
29. Hunter, M.I.S., Niemadim, B.C. and Davidson, D.L.W. (1985). Lipid peroxidation products and antioxidant proteins in plasma and CSF from multiple sclerosis patients. Neurochem.Res. 10, 1645-1652.
30. Hyland, K. and Bottiglieri, T. (1992) Measurement of total plasma and CSF homocysteine by fluorescence detection followed HPLC and pre-column derivatization with OPA. J.Chromatogr. 579, 55-62.
31. Ialenti, A., Ianaro, A., Moncada, S. and DiRosa, M. (1992). Modulation of accute inflammation by endogenous nitric oxide. Eur.J.Pharmacol. 211, 177-182.
32. Ikeda T., Funikawa Y., Mashimoto T., Takahashi K. and Yamada M. (1990). Vitamin B 12 levels in serum and CSF of people with Alzheimer disease. Acta. Psychiatr. Scand 82, 327-329.
33. Ikeda, T., Yamamoto, K., Takahashi, K., Kaku, Y., Uchiyama, M., Sugiyama, K. and Yamada; M. (1992) Treatment of Alzheimer-type dementia with intravenous mecobalamin. Clin.Therapeutics 14, 426-437.
34. Imada, M., Katou T., Kameyam M. and Toyoshima M .(1981). Adsorption and transport of methylcobalamin. In (Kuroiwa G. ed) Nerve System and methyl B12, (pp 23-29), Kyowa Kikatu Tsushin, Tokyo Japan
35. Kaku, S., Tanaka, M., Muramatsu, M. and Otomo, S. (1994) Determination of nitrite by HPLC with EC : Measurement of Nitric oxide synthase activity in rat cerebellum cytosol. J.Biomed.Chromatogr. 8, 24-28.
36. Kaplan, S.L. (1989) Recent Advances in bacterial meningitis. Adv. Pediatr.Infect.Dis. 4, 83-110.
37. Knight, J.A. (1995) Diseases related to oxygen-derived free radicals. Annal Clin.Lab.Sci. 25(2) ,111-121.
38. Koedel, U., Bernatowics, A., Paul, R., Frei, K., Fontana, A. and Pfister, H-W. (1995). Experimental pneumococcal Menigitis : Cerebrovascular alternations, Brain Edema and meningal inflammation are linked to the production of NO. Annal.Neurology 37, 313-323.
39. Kontos, H.A. (1989) Oxygen radicals in CNS damage. Chem.Biol.Interact. 72, 229-236.
40. Koroshetz, W.J., Jenkins, B. and Rosen, B. (1994) Evidence from metabolic disorder in Huntington's disease. Neurology 44 (suppl.2), A338.
41. Lang, A.E. and Fahn, S. (1989) Assessment of Parkinson's disease. In: Munsat. T.L. (ed), Quantification of Neurologi Deficit, Butterworths, Boston, pp. 285-309.
42. Lindenbaum, J., Healton, E.B. and Savage, D.G. (1988) Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. J.Eng.J.Med. 318, 1720-1728.
43. Link, H. and Tibbling, G. (1977) Priciples of albumin and IgG analyses in neurological disorders, III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand.J.Clin.Lab.Invest. 37, 297-301
44. Lipton, J.D. and Schafermeyer, R.W. (1993) Evolving concepts in pediatric bacterial meningitis: Part 1-pathophysiology and diagnosis. Ann.Emerg.Med. 22 1602-1615.
45. Lofton-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
46. McCord, J.M. (1985) Oxygen-derived free radicals in post ischemic tissue injury. N.Engl.J.Med. 321, 159-163.
47. Metz, J. (1992) Cobalamin deficiency and the pathogensis of nervous system disease. Ann.Ren.Nub. 12, 59-79.
48. Moncada, S., Plamer, R.M.J. and Higgs, E.A. (1991). Nitric oxide : Physiology, phathophysiology and pharmacology. Pharmacol. Rev. 43, 109-142.
49. Olanow, C.W. and Arendash, G.W. (1994) Metal and free radicals in neurodegeneration. Current opinion in Neurology 7, 548-558.
50. Qureshi, G.A., Baig, S., Bednar, I., Södersten, P., Forsberg, G. and Siden, Å. (1995) Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. NeuroReport 6, 1642-1644.
51. Qureshi, G.A., Halawa, A. and Baig, S. (1996a) Multiple Sclerosis and Neurotransmission, Biogenic Amines 12(5), 353-376.
52. Qureshi, G.A. Baig, S.M. and Parvez, S.H. (1996b) Biochemical markers in tuberculous meningitis. Biogenic Amines 12(6), 499-519.
53. Qureshi, G.A., Halawa, A., Baig, S.M., Bednar, I. and Parvez, S.H. (1997) The neurochemical markers in cerebrospinal fluid to differentiate between viral and bacterial meningitis J.Neurochem. (in press)
54. Regland, B. (1991) Vitamin B12 defeciency in dementia disorders, Ph.D. thesis, Gothenborg University, Gothenborg , Sweden.
55. Reynolds E.H., Linnell J.C. and Faludy J.E. (1991). Multiple sclerosis associated with vitamin B12 deficiency. Arch. Neurol. 48 , 808-811.
56. Reynold E.H., Bottiglieri T., Laundy M., Crellin R.F., Kirker S.G.(1992). Vitamin B12 metabolism in multiple sclerosis. Arch. Neurol. 49 , 649-652.
57. Rice-Evans, C.A. and Diplock, A.T. (1993) Current status of antioxidant therapy. Free Rad.Biol.Med. 15, 77-96.
58. Rochelle, L.G., Morana, S.J., Kruszyna, H., Russel, M.A., Wilcox, D.E. and Smith, R.P. (1995). Interactions between hydroxocobalamin and nitric oxide: Evidence for redox reaction between nitric oxide and reduced cobalamin and reversible NO binding to oxidized cobalamin.J.Pharm & Exp. Ther.275,48-52.
59. Saez-Llorens, X., Ramilo, O. and Mustafa, M.M. (1990) Molecular Phthophysiology of bacterial meningitis : Current concepts and therpeutic implications, J.Pediatr. 116, 671-684.
60. Schumacher G.A., Becke G., Kibler R.E., Kurland L., Kurtzke J., McDowell F., Nogler B., Sibley W., Tourtellotte W.W. and Willmon T.(1965). Problem on the experimental trails of therapy in Multiple Sclerosis : report by a panel on the evaluation of experimental trails of therapy in Multiple Sclerosis.Ann. N.Y. Acad. Sci. 122, 552-558.
61. Shevell M.I. and Rosenblatt D.S. (1992). The Neurology of Cobalamin. Can. J. Neurol.Sci. 19, 472-486.
62. Sies, H. (1985) Oxidative Stress, Academic Press Inc, Ltd., London.
63. Sies, H. (1991) Oxidative Stress: Oxidants and Antioxidants, Academic Press, London.
64. Smith, C.D., Carney, J.M. and Strake-Reed, P.E. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzehamier's disease.Proc.Natl.Acad.Sci.USA 88, 10540-10543.
65. Snyder, S.H. and Bredt, D.S. (1992) Biological roles of nitric oxide. Science 299, 68-71.
66. Sornäs, R. (1967) A new method for the cytological examination of the cerebrospinal fluid. J.Neurol.Neurosurg.Psych. 30, 568-577.
67. Stamler, J.S., Simon, D.J. and Osborne, J.A. (1992) S-nitrosylation of proteins with nitric oxide : Synthesis and biologically active compounds.Proc.Natl.Acad.Sci. USA 89, 444-448.
68. Starke, K., Gothert, M. and Kilbinger, H. (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol.Rev. 69, 864-889.
69. Stollhoff, K. and Schulte F.J. (1987) Vitamin B 12 and brain development. Eur.J.Paediatr. 146, 201-205.
70. Talan, D.A., Guterman, J.J. and Overturf, G.D. (1988) Influenza of granulocytes of brain edema, intracranial pressure and CSF concentrations of Lactate and protein in experimental meningitis. J.Infect.Dis. 157, 456-459.
71. Watkins, J.C, Krogsgaard-Larsen, P. and Honore, T. (1990) Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitative antagonists. Trends Pharmacol. Sci. 11, 33.
72. Wester, P., Bergström, U. and Eriksson, A. (1990) Venticular cerebrospinal fluid monoamine transmitter and metabolite concentrations refect human brain neurochemistry in autopsy cases. J.Neurochem. 54, 1148-1156.
73. Whetsell, W.O. (1996) Current Concept of excitotoxicity. J.Neuropath.Expt.Neurology 55, 1-13
74. Yagiela, J.A. (1991) health Hazards and nitric oxide : a time for reappriasal. Anesth.Prog. 38, 1-11.
75. Yu, B.P.(1994) cellular defences against damage from reactive oxygen species. Physiol. Rev. 74, 139-162.
76. Yusa, T., Crapo, J.D. and Freeman, B.A. (1984) Lipaso mediated augmentation of brain SOD and catalase inhibits CNS oxygen toxicity. J.Physiol. 57, 1674-1681.
77. Zar, J.H. (1984) Biostatistical Analysis. Englewood Cliffs, Prentice Hall, London.